EEF2K and lung carcinoma: It has been shown that eEF2K is overexpressed and regulates tumor progression in several types of malignancies, including breast cancer, glioma cancer, pancreatic cancer, lung cancer, neuroblastoma, and colorectal cancer [8,21,22].